Cargando…
Dosimetric Quality of Online Adapted Pancreatic Cancer Treatment Plans on an MRI-Guided Radiation Therapy System
PURPOSE: Stereotactic magnetic resonance image–guided adaptive radiation therapy (SMART) is an emerging technique that shows promise in the treatment of pancreatic cancer and other abdominopelvic malignancies. However, it is unknown whether the time-limited nature of on-table adaptive planning may r...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056223/ https://www.ncbi.nlm.nih.gov/pubmed/33898868 http://dx.doi.org/10.1016/j.adro.2021.100682 |
_version_ | 1783680608294141952 |
---|---|
author | Chow, Phillip E. Chu, Fang-I. Agazaryan, Nzhde Cao, Minsong Tyran, Margeurite Yang, Yingli Low, Daniel Raldow, Ann Lee, Percy Steinberg, Michael Lamb, James M. |
author_facet | Chow, Phillip E. Chu, Fang-I. Agazaryan, Nzhde Cao, Minsong Tyran, Margeurite Yang, Yingli Low, Daniel Raldow, Ann Lee, Percy Steinberg, Michael Lamb, James M. |
author_sort | Chow, Phillip E. |
collection | PubMed |
description | PURPOSE: Stereotactic magnetic resonance image–guided adaptive radiation therapy (SMART) is an emerging technique that shows promise in the treatment of pancreatic cancer and other abdominopelvic malignancies. However, it is unknown whether the time-limited nature of on-table adaptive planning may result in dosimetrically suboptimal plans. The purpose of this study was to quantitatively address that question through systemic retrospective replanning of treated on-table adaptive pancreatic cancer cases. METHODS AND MATERIALS: Of 74 consecutive adapted fractions, 30 were retrospectively replanned based on deficiencies in planning target volume (PTV) and gross tumor volume (GTV) coverage or doses to organs-at-risk (OARs) that exceeded ideal constraints. Retrospective plans were created by adjusting dose-volume objectives in an iterative fashion until deemed optimized. The goal of replanning was to improve PTV/GTV coverage while keeping the dose to gastrointestinal OARs the same or lower or to reduce OAR doses while keeping PTV coverage the same or higher. The global maximum dose was required to be maintained within 2% of that of the treated adaptive plan to eliminate it as a confounding factor. A threshold of 5% improvement in PTV coverage or 5% decrease in OAR dose was used to define a clinically significant improvement. RESULTS: Of the 30 replans, 7 obtained at least 5% PTV coverage improvement. The average increase in PTV coverage for these plans was 11%. No plans were clinically significantly improved in terms of OAR sparing. Changes in beam-on time did not show any correlation. Statistical analysis via a linear mixed-effects model with a nested random effect suggested that both GTV and PTV coverage were improved over SMART process plans by 0.91 cc (P = .02) and 2.03 cc (P < .001), respectively. CONCLUSIONS: Dosimetric plan quality of at least 10% of SMART fractions may be improved through more extensive replanning than is currently performed on-table. Further work is needed to develop an automated replanning workflow to streamline the in-depth replanning process to better fit into an on-table adaptive workflow. |
format | Online Article Text |
id | pubmed-8056223 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-80562232021-04-23 Dosimetric Quality of Online Adapted Pancreatic Cancer Treatment Plans on an MRI-Guided Radiation Therapy System Chow, Phillip E. Chu, Fang-I. Agazaryan, Nzhde Cao, Minsong Tyran, Margeurite Yang, Yingli Low, Daniel Raldow, Ann Lee, Percy Steinberg, Michael Lamb, James M. Adv Radiat Oncol Scientific Article PURPOSE: Stereotactic magnetic resonance image–guided adaptive radiation therapy (SMART) is an emerging technique that shows promise in the treatment of pancreatic cancer and other abdominopelvic malignancies. However, it is unknown whether the time-limited nature of on-table adaptive planning may result in dosimetrically suboptimal plans. The purpose of this study was to quantitatively address that question through systemic retrospective replanning of treated on-table adaptive pancreatic cancer cases. METHODS AND MATERIALS: Of 74 consecutive adapted fractions, 30 were retrospectively replanned based on deficiencies in planning target volume (PTV) and gross tumor volume (GTV) coverage or doses to organs-at-risk (OARs) that exceeded ideal constraints. Retrospective plans were created by adjusting dose-volume objectives in an iterative fashion until deemed optimized. The goal of replanning was to improve PTV/GTV coverage while keeping the dose to gastrointestinal OARs the same or lower or to reduce OAR doses while keeping PTV coverage the same or higher. The global maximum dose was required to be maintained within 2% of that of the treated adaptive plan to eliminate it as a confounding factor. A threshold of 5% improvement in PTV coverage or 5% decrease in OAR dose was used to define a clinically significant improvement. RESULTS: Of the 30 replans, 7 obtained at least 5% PTV coverage improvement. The average increase in PTV coverage for these plans was 11%. No plans were clinically significantly improved in terms of OAR sparing. Changes in beam-on time did not show any correlation. Statistical analysis via a linear mixed-effects model with a nested random effect suggested that both GTV and PTV coverage were improved over SMART process plans by 0.91 cc (P = .02) and 2.03 cc (P < .001), respectively. CONCLUSIONS: Dosimetric plan quality of at least 10% of SMART fractions may be improved through more extensive replanning than is currently performed on-table. Further work is needed to develop an automated replanning workflow to streamline the in-depth replanning process to better fit into an on-table adaptive workflow. Elsevier 2021-03-03 /pmc/articles/PMC8056223/ /pubmed/33898868 http://dx.doi.org/10.1016/j.adro.2021.100682 Text en © 2021 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Scientific Article Chow, Phillip E. Chu, Fang-I. Agazaryan, Nzhde Cao, Minsong Tyran, Margeurite Yang, Yingli Low, Daniel Raldow, Ann Lee, Percy Steinberg, Michael Lamb, James M. Dosimetric Quality of Online Adapted Pancreatic Cancer Treatment Plans on an MRI-Guided Radiation Therapy System |
title | Dosimetric Quality of Online Adapted Pancreatic Cancer Treatment Plans on an MRI-Guided Radiation Therapy System |
title_full | Dosimetric Quality of Online Adapted Pancreatic Cancer Treatment Plans on an MRI-Guided Radiation Therapy System |
title_fullStr | Dosimetric Quality of Online Adapted Pancreatic Cancer Treatment Plans on an MRI-Guided Radiation Therapy System |
title_full_unstemmed | Dosimetric Quality of Online Adapted Pancreatic Cancer Treatment Plans on an MRI-Guided Radiation Therapy System |
title_short | Dosimetric Quality of Online Adapted Pancreatic Cancer Treatment Plans on an MRI-Guided Radiation Therapy System |
title_sort | dosimetric quality of online adapted pancreatic cancer treatment plans on an mri-guided radiation therapy system |
topic | Scientific Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056223/ https://www.ncbi.nlm.nih.gov/pubmed/33898868 http://dx.doi.org/10.1016/j.adro.2021.100682 |
work_keys_str_mv | AT chowphillipe dosimetricqualityofonlineadaptedpancreaticcancertreatmentplansonanmriguidedradiationtherapysystem AT chufangi dosimetricqualityofonlineadaptedpancreaticcancertreatmentplansonanmriguidedradiationtherapysystem AT agazaryannzhde dosimetricqualityofonlineadaptedpancreaticcancertreatmentplansonanmriguidedradiationtherapysystem AT caominsong dosimetricqualityofonlineadaptedpancreaticcancertreatmentplansonanmriguidedradiationtherapysystem AT tyranmargeurite dosimetricqualityofonlineadaptedpancreaticcancertreatmentplansonanmriguidedradiationtherapysystem AT yangyingli dosimetricqualityofonlineadaptedpancreaticcancertreatmentplansonanmriguidedradiationtherapysystem AT lowdaniel dosimetricqualityofonlineadaptedpancreaticcancertreatmentplansonanmriguidedradiationtherapysystem AT raldowann dosimetricqualityofonlineadaptedpancreaticcancertreatmentplansonanmriguidedradiationtherapysystem AT leepercy dosimetricqualityofonlineadaptedpancreaticcancertreatmentplansonanmriguidedradiationtherapysystem AT steinbergmichael dosimetricqualityofonlineadaptedpancreaticcancertreatmentplansonanmriguidedradiationtherapysystem AT lambjamesm dosimetricqualityofonlineadaptedpancreaticcancertreatmentplansonanmriguidedradiationtherapysystem |